A61L27/06

PROCESSES FOR ADDITIVELY MANUFACTURING ORTHOPEDIC IMPLANTS

Orthopedic implants produced by additive manufacture, followed by refinement of exterior and interior surfaces trough mechanical erosion, chemical erosion, or a combination of mechanical and chemical erosion. Surface refinement removes debris, and also produces bone-growth enhancing micro-scale and nano-scale structures.

PROCESSES FOR ADDITIVELY MANUFACTURING ORTHOPEDIC IMPLANTS

Orthopedic implants produced by additive manufacture, followed by refinement of exterior and interior surfaces trough mechanical erosion, chemical erosion, or a combination of mechanical and chemical erosion. Surface refinement removes debris, and also produces bone-growth enhancing micro-scale and nano-scale structures.

CUSTOMIZED HYBRID BONE-IMPLANT GRAFTS
20220347348 · 2022-11-03 ·

The present invention provides customized hybrid bone-implant grafts and a method of manufacture thereof.

CUSTOMIZED HYBRID BONE-IMPLANT GRAFTS
20220347348 · 2022-11-03 ·

The present invention provides customized hybrid bone-implant grafts and a method of manufacture thereof.

TITANIUM ALLOY
20170314099 · 2017-11-02 ·

The disclosure relates to a titanium alloy, in particular to be used for biocompatible implants, which contains no aluminum (Al), vanadium (V), cobalt (Co), chromium (Cr), nickel (Ni) and tin (Sn) and contains at least the following alloy components in wt % in addition to inevitable trace amounts of impurities contained in the alloy components or absorbed during the production: a) 0.2 to 1.5% oxygen (O), b) 0.1 to 1.5% iron (Fe), c) 0.01 to 2% carbon (C), d) the remainder being titanium (Ti).

TITANIUM ALLOY
20170314099 · 2017-11-02 ·

The disclosure relates to a titanium alloy, in particular to be used for biocompatible implants, which contains no aluminum (Al), vanadium (V), cobalt (Co), chromium (Cr), nickel (Ni) and tin (Sn) and contains at least the following alloy components in wt % in addition to inevitable trace amounts of impurities contained in the alloy components or absorbed during the production: a) 0.2 to 1.5% oxygen (O), b) 0.1 to 1.5% iron (Fe), c) 0.01 to 2% carbon (C), d) the remainder being titanium (Ti).

SPACER FOR LAMINOPLASTY

A spacer for laminoplasty is provided, the spacer including: a first spacer fixed to an upper lamina plate in a state in which an incision surface of the upper laminate plate of a lamina plate of an incised cervical vertebrae is seated on and supported by the first spacer; and a second spacer fixed to a lower lamina plate so that an incision surface of the lower lamina plate of the lamina plate of the incised cervical vertebrae is in contact with and supported by the second spacer, wherein the first spacer and the second spacer are in a coupled state in which they are not separated from each other by a fixed bar, while having expandable lengths with respect to each other.

SPACER FOR LAMINOPLASTY

A spacer for laminoplasty is provided, the spacer including: a first spacer fixed to an upper lamina plate in a state in which an incision surface of the upper laminate plate of a lamina plate of an incised cervical vertebrae is seated on and supported by the first spacer; and a second spacer fixed to a lower lamina plate so that an incision surface of the lower lamina plate of the lamina plate of the incised cervical vertebrae is in contact with and supported by the second spacer, wherein the first spacer and the second spacer are in a coupled state in which they are not separated from each other by a fixed bar, while having expandable lengths with respect to each other.

Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal

Adult autologous stem cells cultured on a porous, three-dimensional tissue scaffold-implant for bone regeneration by the use of a hyaluronan and/or dexamethasone to accelerate bone healing alone or in combination with recombinant growth factors or transfected osteogenic genes. The scaffold-implant may be machined into a custom-shaped three-dimensional cell culture system for support of cell growth, reservoir for peptides, recombinant growth factors, cytokines and antineoplastic drugs in the presence of a hyaluronan and/or dexamethasone alone or in combination with growth factors or transfected osteogenic genes, to be assembled ex vivo in a tissue incubator for implantation into bone tissue.

GEARED CONTINUOULSLY VARIABLE TRANSMISSION
20170299034 · 2017-10-19 ·

A geared continuously variable transmission (GCVT) is provided. The GCVT includes a first set of solar gears having a first solar gear and first plurality of connection components. Power enters the GCVT through the first set of solar gears. The GCVT includes a second set of solar gears having a second solar gear and second plurality of connection components. Power exits the GCVT through the second set of solar gears. Power is transmitted from the first set of solar gears to the second set of solar gears via the first plurality of connection components and the second plurality of connection components. The GCVT includes a hydraulic pump and a hydraulic motor connecting first component from the first plurality of connection components to second component from the second plurality of connection components and providing constant rotation ratio between the first component and the second component.